The instant invention relates to a combination of an EP4-receptor antagonist and an alpha-2-delta ligand, and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly inflammatory,
-
(2008/06/13)
COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS AND NMDA RECEPTOR ANTAGONISTS
The instant invention relates to a synergistic combination of an alpha-2-delta ligand and an NMDA, suitably NR2B, receptor antagonist, or pharmaceutically acceptable salts, esters or solvates thereof, pharmaceutical compositions thereof and their use in t
-
(2010/02/14)
COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS
The instant invention relates to a combination, particularly a synergistic combination, of an alpha-2-delta ligand and an atypical antipsychotic, and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly neuropathic pain.
-
Page/Page column 36-37
(2010/02/14)
More Articles about upstream products of 866108-42-1